Table 2.
Summary of MTT, drug release, antioxidant and anticancerous activity.
| S. No | Particle | IC50 (MTT) | Size Analysis | Antioxidant Activity | In vitro drug release | |||
|---|---|---|---|---|---|---|---|---|
| % RSA | Reducing power | Total Phenolic content | PBS (pH 7.4) | Acetate buffer (pH 5.2) | ||||
| 1 | A1 | 112 µg/ml | 119.8 nm | 73% | 0.190 | 120 μg phenol/300 μg β-Glucan | – | – |
| 2 | A2 | 94 µg/ml | 132.8 nm | 86% | 0.545 | 150 μg Phenol/300 μg β-Glucan + Q | 88% | 32% |
| 3 | A3 | 45 µg/ml | 214.1 nm | – | – | – | 70% | 79% |
| 4 | Y1 | 175 µg/ml | 161.9 nm | 64% | 0.176 | 10 μg phenol/300 μg of beta glucan | – | – |
| 5 | Y2 | 200 µg/ml | 113.5 nm | 77% | 0.596 | 96 μg phenol/300 μg of β-Glucan + Q | 86% | 93% |
| 6 | Y3 | 150 µg/ml | 156.9 nm | – | – | – | 70% | 75% |